Trials / Completed
CompletedNCT04000230
Teacher Child Interaction Training (TCIT): Randomized Control Trial
Teacher-Child Interaction Training in Miami-Dade County Early Education Programs: A Randomized Control Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 622 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 12 Months
- Healthy volunteers
- Accepted
Summary
This study is being conducted to evaluate the effects of TCIT on child development, child behavior, and teacher use of skills in the classroom.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | TCIT | TCIT consists of the following: * CDI Teach Session: Teachers will participate in two training workshops in Child-Directed Interaction (CDI) skills. Specifically, teachers will learn to use positive attention skills and active ignoring. * CDI Coaching: Teachers will receive 90 minutes of CDI coaching in the classroom once or twice weekly for 6 total coaching sessions over a period of 4-6 weeks. The coach will observe the class and coach the teacher live using a microphone and bug-in-the-ear device. * TDI Teach Session: Teachers will complete two training workshops in Teacher Directed Interaction (TDI) skills, which focus on increasing compliance and reducing disruptive behavior. Teachers will learn to present developmentally appropriate, direct, and clear instructions and consistent positive and negative consequences. * TDI Coaching: Teachers will receive six 90-minute TDI coaching sessions once or twice weekly for 4-6 weeks. |
| BEHAVIORAL | Booster | Teachers in the Intervention group will receive additional booster sessions during the second half of the school year. Booster sessions consist of coaching teachers in CDI and TDI skills. Teachers receive 4-8 booster sessions. |
Timeline
- Start date
- 2017-07-07
- Primary completion
- 2021-07-30
- Completion
- 2021-07-30
- First posted
- 2019-06-27
- Last updated
- 2021-08-03
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04000230. Inclusion in this directory is not an endorsement.